Barclays’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $233K | Sell |
9,009
-6,776
| -43% | -$175K | ﹤0.01% | 3445 |
|
2025
Q1 | $160K | Sell |
15,785
-5,936
| -27% | -$60.2K | ﹤0.01% | 3450 |
|
2024
Q4 | $303K | Sell |
21,721
-2,165
| -9% | -$30.2K | ﹤0.01% | 3325 |
|
2024
Q3 | $466K | Buy |
23,886
+11,706
| +96% | +$228K | ﹤0.01% | 3034 |
|
2024
Q2 | $227K | Sell |
12,180
-26,018
| -68% | -$485K | ﹤0.01% | 2982 |
|
2024
Q1 | $535K | Buy |
38,198
+338
| +0.9% | +$4.73K | ﹤0.01% | 2792 |
|
2023
Q4 | $321K | Buy |
37,860
+22,537
| +147% | +$191K | ﹤0.01% | 3269 |
|
2023
Q3 | $137K | Buy |
15,323
+11,501
| +301% | +$103K | ﹤0.01% | 3198 |
|
2023
Q2 | $33K | Sell |
3,822
-6,362
| -62% | -$54.9K | ﹤0.01% | 3845 |
|
2023
Q1 | $108K | Sell |
10,184
-743
| -7% | -$7.88K | ﹤0.01% | 3486 |
|
2022
Q4 | $372K | Buy |
10,927
+1,297
| +13% | +$44.2K | ﹤0.01% | 2762 |
|
2022
Q3 | $463K | Sell |
9,630
-7,406
| -43% | -$356K | ﹤0.01% | 2630 |
|
2022
Q2 | $971K | Buy |
17,036
+4,238
| +33% | +$242K | ﹤0.01% | 2100 |
|
2022
Q1 | $1.04M | Buy |
12,798
+7,574
| +145% | +$613K | ﹤0.01% | 2279 |
|
2021
Q4 | $1.06M | Sell |
5,224
-4,097
| -44% | -$831K | ﹤0.01% | 2168 |
|
2021
Q3 | $2.51M | Sell |
9,321
-4,637
| -33% | -$1.25M | ﹤0.01% | 1703 |
|
2021
Q2 | $3.59M | Buy |
13,958
+12,790
| +1,095% | +$3.29M | ﹤0.01% | 1381 |
|
2021
Q1 | $350K | Sell |
1,168
-1,249
| -52% | -$374K | ﹤0.01% | 2862 |
|
2020
Q4 | $616K | Sell |
2,417
-11,357
| -82% | -$2.89M | ﹤0.01% | 2235 |
|
2020
Q3 | $3.43M | Sell |
13,774
-2,793
| -17% | -$695K | ﹤0.01% | 1168 |
|
2020
Q2 | $5.76M | Sell |
16,567
-6,731
| -29% | -$2.34M | ﹤0.01% | 862 |
|
2020
Q1 | $6.24M | Buy |
23,298
+12,461
| +115% | +$3.34M | ﹤0.01% | 778 |
|
2019
Q4 | $3.51M | Sell |
10,837
-22,229
| -67% | -$7.2M | ﹤0.01% | 1491 |
|
2019
Q3 | $9.03M | Buy |
33,066
+16,365
| +98% | +$4.47M | 0.01% | 820 |
|
2019
Q2 | $8.91M | Buy |
16,701
+1,976
| +13% | +$1.05M | 0.01% | 867 |
|
2019
Q1 | $7.42M | Buy |
14,725
+281
| +2% | +$142K | 0.01% | 849 |
|
2018
Q4 | $7.12M | Sell |
14,444
-4,846
| -25% | -$2.39M | 0.01% | 829 |
|
2018
Q3 | $17.6M | Sell |
19,290
-7,610
| -28% | -$6.96M | 0.01% | 582 |
|
2018
Q2 | $19.7M | Buy |
26,900
+7,978
| +42% | +$5.84M | 0.02% | 501 |
|
2018
Q1 | $30.2M | Sell |
18,922
-7,065
| -27% | -$11.3M | 0.02% | 434 |
|
2017
Q4 | $23.3M | Buy |
25,987
+10,525
| +68% | +$9.43M | 0.02% | 441 |
|
2017
Q3 | $5.57M | Buy |
15,462
+3,167
| +26% | +$1.14M | 0.01% | 769 |
|
2017
Q2 | $3.61M | Sell |
12,295
-9,192
| -43% | -$2.7M | ﹤0.01% | 928 |
|
2017
Q1 | $7.56M | Buy |
21,487
+15,004
| +231% | +$5.28M | 0.01% | 631 |
|
2016
Q4 | $1.19M | Buy |
6,483
+6,158
| +1,895% | +$1.13M | ﹤0.01% | 1399 |
|
2016
Q3 | $83K | Sell |
325
-430
| -57% | -$110K | ﹤0.01% | 2510 |
|
2016
Q2 | $160K | Buy |
755
+521
| +223% | +$110K | ﹤0.01% | 2193 |
|
2016
Q1 | $45K | Sell |
234
-2,347
| -91% | -$451K | ﹤0.01% | 2570 |
|
2015
Q4 | $620K | Sell |
2,581
-226
| -8% | -$54.3K | ﹤0.01% | 1582 |
|
2015
Q3 | $421K | Buy |
2,807
+348
| +14% | +$52.2K | ﹤0.01% | 1800 |
|
2015
Q2 | $443K | Sell |
2,459
-2,114
| -46% | -$381K | ﹤0.01% | 1813 |
|
2015
Q1 | $754K | Sell |
4,573
-1,923
| -30% | -$317K | ﹤0.01% | 1726 |
|
2014
Q4 | $1.46M | Buy |
6,496
+4,744
| +271% | +$1.07M | ﹤0.01% | 1446 |
|
2014
Q3 | $316K | Sell |
1,752
-27,440
| -94% | -$4.95M | ﹤0.01% | 2133 |
|
2014
Q2 | $5.26M | Buy |
29,192
+18,793
| +181% | +$3.38M | 0.01% | 928 |
|
2014
Q1 | $1.87M | Buy |
10,399
+8,818
| +558% | +$1.59M | ﹤0.01% | 1359 |
|
2013
Q4 | $260K | Sell |
1,581
-32,384
| -95% | -$5.33M | ﹤0.01% | 2486 |
|
2013
Q3 | $5.09M | Buy |
33,965
+18,072
| +114% | +$2.71M | 0.01% | 878 |
|
2013
Q2 | $2.75M | Buy |
+15,893
| New | +$2.75M | ﹤0.01% | 1130 |
|